Register entry
- Registered sites
- 0
- Active NDC listings
- 6
- Live patents
- 9
- Countries
- 0
Catalogue
Drug listings by form and route
66 active NDC listings: 6 human prescription drug. By marketing category: NDA 6.
| Dosage form | NDCs |
|---|---|
| injection, solution | 4 |
| tablet | 2 |
| Route | NDCs |
|---|---|
| subcutaneous | 4 |
| oral | 2 |
| Labeller name on the listing | NDCs |
|---|---|
| xeris pharmaceuticals, inc. | 6 |
Exclusivity
Patents and exclusivities
9| Patent | Product | Covers | Expiry |
|---|---|---|---|
| 11590205 | GVOKE HYPOPEN, GVOKE KIT, GVOKE PFSglucagon | product | Apr 2036 |
| 9649364 | GVOKE HYPOPEN, GVOKE PFSglucagon | product | Apr 2036 |
Catalogue
Marketed products
6| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| Gvoke HypoPen 0.5 mg Auto-Injector | glucagon injection, solution | injection, solution, subcutaneous | 72065-120NDA |
| Gvoke HypoPen 1 mg Auto-Injector | glucagon injection, solution | injection, solution, subcutaneous | 72065-121NDA |
| Gvoke Kit | glucagon injection, solution | injection, solution, subcutaneous | 72065-140NDA |
| Gvoke PFS 1 mg Pre-filled Syringe | glucagon injection, solution | injection, solution, subcutaneous | 72065-131NDA |
| Keveyis | Dichlorphenamide | tablet, oral | 72065-001NDA |
| Recorlev | Levoketoconazole | tablet, oral | 72065-003NDA |
Enquiry
Common questions
- Is Xeris Pharmaceuticals, Inc. FDA approved?
- Xeris Pharmaceuticals, Inc. holds no registered establishment of its own; 6 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does Xeris Pharmaceuticals, Inc. make?
- 6 products are listed under Xeris Pharmaceuticals, Inc. in the openFDA NDC Directory, most often as injection, solution; tablet. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.